Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Douglas Plassche Insider Profile
4 Followers
Douglas Plassche, Executive VP Operations at Elite Pharmaceuticals, holds 1.13M shares in Elite Pharmaceuticals (Ticker: ELTP).
Douglas Plassche has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Douglas Plassche's holdings
Insider Roles
Executive VP Operations
Roles that Douglas Plassche holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Apr 28, 2015 - Apr 28, 2016
Return:-40.60%
The most profitable trade made by Douglas Plassche
Douglas Plassche's Trading History
List of latest transactions for each holding click on a transaction to see Douglas Plassche's performance on stock
You May Also Like
Douglas Plassche insider profile FAQ
What is the percentage of profitable transactions made by Douglas Plassche?
The percentage of profitable transactions made by Douglas Plassche is ―.
What is the average return per transaction made by Douglas Plassche?
The average return per transaction made by Douglas Plassche is ―.
What stocks does Douglas Plassche hold?
Douglas Plassche holds: ELTP stocks.
What was Douglas Plassche’s latest transaction?
Douglas Plassche latest transaction was an Uninformative Buy of $5.74K.
What was Douglas Plassche's most profitable transaction?
Douglas Plassche’s most profitable transaction was an Informative Sell of ELTP stock on April 28, 2015. The return on the trade was -40.60%.
What is Douglas Plassche's role in Elite Pharmaceuticals?
Douglas Plassche's role in Elite Pharmaceuticals is Executive VP Operations.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.